Lichen China Limited Class A Ordinary Shares (LICN) has had the highest return since January 1, 2025 by a US stock in the Nasdaq Composite (IXIC), returning 2,856.5%.
| ASSET | % RETURN |
|---|---|
Lichen China Limited Class A Ordinary Shares (LICN) | 2,856.52% |
Dominari (DOMH) | 704.93% |
Neuronetics (STIM) | 228.48% |
Jiuzi (JZXN) | 223.57% |
Rapid Micro Biosystems (RPID) | 198.9% |
Yoshiharu Global (YOSH) | 198.48% |
Avalon GloboCare (ALBT) | 196.93% |
Wang & Lee Group, Inc Ordinary Shares (WLGS) | 182.18% |
Creative Medical Technology (CELZ) | 179.22% |
Cumberland Pharmaceuticals (CPIX) | 177.46% |
Reborn Coffee (REBN) | 174.27% |
VNET Group Inc DRC (VNET) | 161.97% |
Chimerix (CMRX) | 141.03% |
Energy Focu (EFOI) | 128.33% |
Invivyd (IVVD) | 125.53% |
Lottery, Inc Common Stock (LTRY) | 123.64% |
Biomerica (BMRA) | 120.52% |
Noodles (NDLS) | 120.5% |
Oncology Institute (TOI) | 115.2% |
GRAIL, LLC (GRAL) | 114.93% |
Coffee (JVA) | 112.36% |
Gorilla Technology (GRRR) | 110.71% |
Xunlei Ltd Adr (XNET) | 108.33% |
Lightbridge (LTBR) | 106.68% |
Digital Turbine (APPS) | 105.75% |
